Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Access to healthcare

Activists demand cheaper Hepatitis C drugs

Editor's pick
Jakarta Post
30 July 2013
Access to healthcare

To End Hepatitis C, Patients Must Come Before Profits

Editor's pick
Huffington Post
30 July 2013
Hepatitis C transmission & prevention

Vietnam responses to World Hepatitis Day

Editor's pick
Xinhua
29 July 2013
People who inject drugs

Head of UN drug agency calls for prevention, fair access to treatment on World Hepatitis Day

Editor's pick
UN News Centre
29 July 2013
Experiences of stigma

Hep C stigma as a pharmaceutical marketing device

Editor's pick
Bad Blood (blog)
27 July 2013
Hepatitis C treatment

The time bomb is ticking….Defuse hepatitis C, the viral time bomb!

Editor's pick
HepCoalition
25 July 2013
Hepatitis C treatment

Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C

Editor's pick
Medical Xpress
25 July 2013
Hepatitis C treatment

Hepatitis treatment debuts on WHO Model Essential Medicines List

Editor's pick
World Health Organization (press release)
25 July 2013
New & experimental hepatitis C treatment

Are Patients Receiving the Latest Anti-HCV Drugs?

Editor's pick
AGA Journals blog
22 July 2013
New & experimental hepatitis C treatment

How to Save $200 Billion and Cure Hepatitis C

Editor's pick
Xconomy
22 July 2013
Hepatitis C treatment

NICE draft guidance recommends drugs to treat chronic hepatitis C in children and young people

Editor's pick
NICE
19 July 2013
Treatment outcomes & life expectancy

Poor treatment outcomes common among children with HIV/HCV coinfection

Editor's pick
Healio.com
9 July 2013
Hepatitis C treatment

INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)

Editor's pick
PR Newswire
31 May 2013
Hepatitis C treatment

Recent Advances in the Treatment of Chronic Hepatitis C Threaten to Leave Some Parts of the World Behind

Editor's pick
Medscape (requires registration)
21 May 2013
New & experimental hepatitis C treatment

Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets

Editor's pick
PR Newswire
1 May 2013
Hepatitis C treatment

Hepatitis C Viral Load Fluctuates Without Treatment

Editor's pick
Medscape (requires registration)
5 April 2013
Hepatitis C treatment

Integrated Psych Care for High-Risk Hep C Patients May Increase Antiviral Treatment

Editor's pick
Medscape (requires registration)
27 March 2013
Hepatitis C treatment

Once-Daily Ribavirin Promising for Hepatitis C

Editor's pick
Medscape (requires registration)
27 March 2013
Hepatitis C treatment

Pakistan: Hepatitis C treatment: Expatriate scientists weigh in on interferon issue

Editor's pick
The Express Tribune
26 March 2013
Hepatitis C treatment

Patients with HCV may deliberately skip early treatment doses when feeling well

Editor's pick
Healio Hepatology
26 March 2013
Hepatitis C treatment

Roche’s Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older

Editor's pick
Roche press release
19 March 2013
Hepatitis C treatment

Telaprevir shows promise in black patients with genotype 1 HCV

Editor's pick
Healio
12 March 2013
Hepatitis C treatment

Patient Dilemma: Treat Hepatitis C Now or Hold Out?

Editor's pick
Wall Street Journal
5 March 2013
Hepatitis C treatment

Milk Thistle Drug May Help Control HCV Replication after Liver Transplant

Editor's pick
HIVandhepatitis.com
2 March 2013